choose content

Choose content

Enter keywords to create a newsletter
create account

Create account

Enter your registration information
set preferences

Set preferences

Set up your newsletter name, delivery and time zone preferences
Hint: Enter different keywords to generate new results.

Now you can:

  1. Search the news index.
  2. Browse more than 1 million newsletters by category.
  3. Use preset newsletters:
    • Melanoma Drugs

Melanoma Drugs Newsletter
  • Moffitt Researchers Discover Possible New Treatment Strategy for Lung Cancer 20 Aug 2019 16:26 GMT

    … more aggressive and difficult to treat. Researchers at Moffitt Cancer … targets. For example, in melanoma, therapies that target the BRAF … for lung cancer treatment. Through a series of drug screens, cell … signaling is a viable treatment strategy for lung cancer …

  • How doctors intend to use human waste to treat skin cancer 20 Aug 2019 13:41 GMT

    … to the immunotherapy drugs. Twenty melanoma patients from the … first clinical trial of the new treatment. The fecal … treatment combination, but researchers will also evaluate patient outcomes. "Melanoma … already been used to treat patients with recurrent C …

  • MGEN Shines, NBRV Breathes Easy, SRPT Slips On FDA Snub 20 Aug 2019 06:39 GMT

    … proteins that could prevent, treat, or cure a disease. … for the adjuvant treatment of high-risk resectable melanoma. -- Phase … adenocarcinoma. -- Phase I trial of MEDI1191 injected intratumorally … was snubbed by the FDA is Vanda Pharmaceuticals Inc. (VNDA). …

  • Study uncovers potential new treatment approach for lung cancer 20 Aug 2019 03:43 GMT

    … more aggressive and difficult to treat. Researchers at Moffitt Cancer … targets. For example, in melanoma, therapies that target the BRAF … for lung cancer treatment. Through a series of drug screens, cell … signaling is a viable treatment strategy for lung cancer …

  • ASDS Members Performed More Than 12.5 Million Treatments in 2018 20 Aug 2019 01:08 GMT

    … Procedures revealed skin cancer treatments are persistently the … million skin cancer treatments in 2018. Melanoma – the deadliest … increasing 78 percent. Body treatments gain increasing popularity, … training and experience to treat the health, function and …

  • Could Poop Be The Next Treatment For Cancer? 19 Aug 2019 15:41 GMT

    … improve outcomes in melanoma patients. This is the first trial of its … of fecal transplants." Immunotherapy drugs, which spur a patient… of anti-PD-1 immunotherapy drugs. To do this, they … see its potential for the treatment of other diseases." The …

  • How human poo 'transplants' could help doctors treat deadliest form of skin cancer 19 Aug 2019 15:01 GMT

    … to the immunotherapy drugs. Twenty melanoma patients from the … first clinical trial of the new treatment. The fecal … treatment combination, but researchers will also evaluate patient outcomes. "Melanoma … already been used to treat patients with recurrent C …

  • Scancell Says Decided to Withdraw IND Application In U.S. To Allow UK Arm OF SCIB1 Trial To Proceed 19 Aug 2019 11:11 GMT

    … OF TRIAL TO PROCEED.SCANCELL HOLDINGS - WILL RESUBMIT INVESTIGATIONAL NEW DRUG … STUDY IN PATIENTS WITH ADVANCED MELANOMA.FDA REQUESTED ADDITIONAL INFORMATION, WITH RESPECT … PLC - SCIB2 IS FOR TREATMENT OF PATIENTS WITH SOLID TUMOURS …

  • Scancell postpones US part of clinical trial following regulatory delay 19 Aug 2019 07:54 GMT

    StockMarketWire.com - Immunotherapy treatment for cancer developer Scancell said … SCIB1 Phase 2 trial in patients with metastatic melanoma, in both the … the Investigational New Drug (IND) application submitted to the FDA, prior approval …

  • Study explores if fecal transplants can improve outcomes in melanoma patients 19 Aug 2019 05:36 GMT

    … . In a phase I clinical trial, the research team is the … novel treatment combination, but researchers will also evaluate patient outcomes. "Melanoma … LHSC. "Anti-PD1 immunotherapy drugs can be extremely effective but …

Satisfied with the content?

Continue to create your account.